We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Bioporto AS (BIOPOR) DKK1

Sell:1.63 DKK Buy:1.64 DKK Change: 0.17 DKK (11.35%)
Market closed |  Prices as at close on 8 May 2024 | Switch to live prices |
Sell:1.63 DKK
Buy:1.64 DKK
Change: 0.17 DKK (11.35%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 8 May 2024 | Switch to live prices |
Sell:1.63 DKK
Buy:1.64 DKK
Change: 0.17 DKK (11.35%)
Market closed |  Prices as at close on 8 May 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Bioporto A/S is a Denmark-based company engaged in the development and marketing of in vitro diagnostic (IVD) assays. The Company’s portfolio comprises five product categories: The Neutrophil gelatinase-associated lipocalin (NGAL) Test, which is a test for diagnosing acute kidney injury; NGAL Enzyme-linked immunosorbent assay (ELISA) kits, which supplies NGAL for the development of medicines for estimating side-effects that are harmful to kidneys; Mannan-binding Lectin (MBL) ELISA kit, which offers monoclonal MBL antibodies that are responsible for the activation of immune response; Antibodies, including monoclonal antibodies used in a range of research areas, such as microbiology, biomarkers, peptide hormones and plasma proteins; and Activated Protein C with Protein C Inhibitor Complex (APC-PCI), a biomarker applied to patients with sepsis and thrombotic and hemostatic disorders. In addition, the Company is a parent of BioPorto Diagnostics A/S.

Contact details

Address:
Tuborg Havnevej 15, St.
HELLERUP
2900
Denmark
Telephone:
+45 (45) 290000
Website:
https://bioporto.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
BIOPOR
ISIN:
DK0011048619
Market cap:
555.08 million DKK
Shares in issue:
379.66 million
Sector:
Biotechnology
Exchange:
Copenhagen Stock Exchange
Country:
Denmark
Currency:
Danish Krone
Indices:
n/a

Key personnel

  • John Mcdonough
    Chairman of the Board
  • Peter Moerch Eriksen
    Group Chief Executive Officer
  • Torben Nielsen
    Vice Chairman of the Board
  • Jan Kuhlmann Andersen
    Chief Operation Officer
  • Finn Fjorder
    Executive Vice President Sales
  • Gry Larsen
    Executive Vice President and Chief Legal Officer
  • Christopher Bird
    Chief Medical Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.